Treating pulmonary hypertension in COPD: where do we start?

Hoeper M. M.

Source: Eur Respir J 2008; 32: 541-542
Journal Issue: September
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hoeper M. M.. Treating pulmonary hypertension in COPD: where do we start?. Eur Respir J 2008; 32: 541-542

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005

Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019


Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019



Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005

Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD?
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Pulmonary hypertension in the elderly: a different disease?
Source: Breathe 2016; 12: 43-49
Year: 2016


Interdisciplinary rehabilitation in pulmonary hypertension: can we learn from chronic obstructive pulmonary disease or heart failure?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018


Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018


When is pulmonary hypertension not pulmonary hypertension?
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001

Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension?
Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020
Year: 2020



Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014


Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005

Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014


Should COPD stand for “comorbidity-related obstructive pulmonary disease”?
Source: Eur Respir J 2015; 46: 901-902
Year: 2015


Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Pulmonary hypertension in COPD: Prevalence and characteristics
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012